Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jan;13(1):65-76.
doi: 10.1016/S1473-3099(12)70273-6.

Combination implementation for HIV prevention: moving from clinical trial evidence to population-level effects

Affiliations
Review

Combination implementation for HIV prevention: moving from clinical trial evidence to population-level effects

Larry W Chang et al. Lancet Infect Dis. 2013 Jan.

Abstract

The promise of combination HIV prevention-the application of multiple HIV prevention interventions to maximise population-level effects-has never been greater. However, to succeed in achieving significant reductions in HIV incidence, an additional concept needs to be considered: combination implementation. Combination implementation for HIV prevention is the pragmatic, localised application of evidence-based strategies to enable high sustained uptake and quality of interventions for prevention of HIV. In this Review, we explore diverse implementation strategies including HIV testing and counselling models, task shifting, linkage to and retention in care, antiretroviral therapy support, behaviour change, demand creation, and structural interventions, and discusses how they could be used to complement HIV prevention efforts such as medical male circumcision and treatment as prevention. HIV prevention and treatment have arrived at a pivotal moment when combination efforts might result in substantial enough population-level effects to reverse the epidemic and drive towards elimination of HIV. Only through careful consideration of how to implement and operationalise HIV prevention interventions will the HIV community be able to move from clinical trial evidence to population-level effects.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

We declare that we have no conflicts of interest.

Comment in

  • Children and adolescents with HIV.
    Binagwaho A, Nutt CT, Nsanzimana S, Wagner CM, Mukherjee JS. Binagwaho A, et al. Lancet Infect Dis. 2013 Aug;13(8):654. doi: 10.1016/S1473-3099(13)70188-9. Lancet Infect Dis. 2013. PMID: 23886330 No abstract available.

References

    1. Kurth A, Celum C, Baeten J, Vermund S, Wasserheit J. Combination HIV Prevention: Significance Challenges, and Opportunities. 2011;(1):62–72. - PMC - PubMed
    1. Piot P, Bartos M, Larson H, Zewdie D, Mane P. Coming to terms with complexity: a call to action for HIV prevention. The Lancet. 2008;372(9641):845–859. - PubMed
    1. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. The New England journal of medicine. 2011;365(6):493–505. - PMC - PubMed
    1. Padian NS, McCoy SI, Karim SS, et al. HIV prevention transformed: the new prevention research agenda. Lancet. 2011;378(9787):269–278. - PMC - PubMed
    1. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369(9562):643–656. - PubMed

Publication types

MeSH terms

Substances